Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1984 1
1989 2
1993 1
1995 1
1999 2
2000 1
2003 1
2004 4
2005 3
2006 2
2007 3
2008 3
2009 1
2010 2
2011 4
2012 4
2013 1
2014 5
2015 1
2016 2
2017 1
2018 3
2019 3
2020 5
2021 5
2022 1
Text availability
Article attribute
Article type
Publication date

Search Results

52 results
Results by year
Filters applied: . Clear all
Page 1
Ten-year results of the PORTEC-2 trial for high-intermediate risk endometrial carcinoma: improving patient selection for adjuvant therapy.
Wortman BG, Creutzberg CL, Putter H, Jürgenliemk-Schulz IM, Jobsen JJ, Lutgens LCHW, van der Steen-Banasik EM, Mens JWM, Slot A, Kroese MCS, van Triest B, Nijman HW, Stelloo E, Bosse T, de Boer SM, van Putten WLJ, Smit VTHBM, Nout RA; PORTEC Study Group. Wortman BG, et al. Among authors: slot a. Br J Cancer. 2018 Oct;119(9):1067-1074. doi: 10.1038/s41416-018-0310-8. Epub 2018 Oct 25. Br J Cancer. 2018. PMID: 30356126 Free PMC article. Clinical Trial.
PORTEC-4a: international randomized trial of molecular profile-based adjuvant treatment for women with high-intermediate risk endometrial cancer.
van den Heerik ASVM, Horeweg N, Nout RA, Lutgens LCHW, van der Steen-Banasik EM, Westerveld GH, van den Berg HA, Slot A, Koppe FLA, Kommoss S, Mens JWM, Nowee ME, Bijmolt S, Cibula D, Stam TC, Jurgenliemk-Schulz IM, Snyers A, Hamann M, Zwanenburg AG, Coen VLMA, Vandecasteele K, Gillham C, Chargari C, Verhoeven-Adema KW, Putter H, van den Hout WB, Wortman BG, Nijman HW, Bosse T, Creutzberg CL. van den Heerik ASVM, et al. Among authors: slot a. Int J Gynecol Cancer. 2020 Dec;30(12):2002-2007. doi: 10.1136/ijgc-2020-001929. Epub 2020 Oct 12. Int J Gynecol Cancer. 2020. PMID: 33046573 Free PMC article.
Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial.
Nout RA, Smit VT, Putter H, Jürgenliemk-Schulz IM, Jobsen JJ, Lutgens LC, van der Steen-Banasik EM, Mens JW, Slot A, Kroese MC, van Bunningen BN, Ansink AC, van Putten WL, Creutzberg CL; PORTEC Study Group. Nout RA, et al. Among authors: slot a. Lancet. 2010 Mar 6;375(9717):816-23. doi: 10.1016/S0140-6736(09)62163-2. Lancet. 2010. PMID: 20206777 Clinical Trial.
Radiation Oncology in The Netherlands.
Slotman BJ, Vos P, Slot A, Keus R, Verheij M. Slotman BJ, et al. Among authors: slot a. Int J Radiat Oncol Biol Phys. 2018 Jan 1;100(1):5-11. doi: 10.1016/j.ijrobp.2017.09.005. Int J Radiat Oncol Biol Phys. 2018. PMID: 29254780 No abstract available.
Stauffer's syndrome: A true entity?
van Roekel C, Slot ASB, Viddeleer AC, van Erpecum KJ, Lock MTWT. van Roekel C, et al. Among authors: slot asb. Clin Res Hepatol Gastroenterol. 2021 Jan;45(1):101515. doi: 10.1016/j.clinre.2020.07.020. Epub 2020 Dec 29. Clin Res Hepatol Gastroenterol. 2021. PMID: 33385831 Free article. No abstract available.
Mammalian multidrug-resistance proteins (MRPs).
Slot AJ, Molinski SV, Cole SP. Slot AJ, et al. Essays Biochem. 2011 Sep 7;50(1):179-207. doi: 10.1042/bse0500179. Essays Biochem. 2011. PMID: 21967058 Review.
Brachytherapy quality assurance in the PORTEC-4a trial for molecular-integrated risk profile guided adjuvant treatment of endometrial cancer.
Wortman BG, Astreinidou E, Laman MS, van der Steen-Banasik EM, Lutgens LCHW, Westerveld H, Koppe F, Slot A, van den Berg HA, Nowee ME, Bijmolt S, Stam TC, Zwanenburg AG, Mens JWM, Jürgenliemk-Schulz IM, Snyers A, Gillham CM, Weidner N, Kommoss S, Vandecasteele K, Tomancova V, Creutzberg CL, Nout RA; PORTEC Study Group. Wortman BG, et al. Among authors: slot a. Radiother Oncol. 2021 Feb;155:160-166. doi: 10.1016/j.radonc.2020.10.038. Epub 2020 Nov 5. Radiother Oncol. 2021. PMID: 33159971 Free article.
52 results